MindMed Reports Full Year 2021 Financial Results and Business Highlights
Marijuana Stocks, Finance, & InvestingUncategorized March 28, 2022
– FDA cleared MindMed’s Investigational New Drug (IND) application for Phase 2b dose optimization trial of MM-120 – – Progressed development programs for all three lead product candidates – – Cash balance of $133.5 million at year end 2021 – – Company to host earnings conference call today at 8:30…
Read more3 Marijuana Stocks To Watch Heading Into Next Month
The post 3 Marijuana Stocks To Watch Before April Begins appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Read moreCara Therapeutics, Inc. (CARA) Announces Oral KORSUVA™ (difelikefalin) Improves Itch and Inflammatory Biomarkers
Marijuana Industry NewsUncategorized March 28, 2022
Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Improves Itch and Inflammatory Biomarkers in…
The post Cara Therapeutics, Inc. (CARA) Announces Oral KORSUVA™ (difelikefalin) Improves Itch and Inflammatory Biomarkers appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Read moreThese Pot Stocks Should Be On Your Watchlist This Week
The post Top Canadian Marijuana Stocks To Buy? 3 To Watch Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Read moreCommittee Blog: Protect Against Corporate Identity Theft with Trademark Rights
Marijuana Laws, Regulations, & Politics March 28, 2022 0
House poised to pass bill legalizing marijuana
Marijuana Industry NewsMedical MarijuanaRecreational Marijuana March 28, 2022 0
What’s ahead for recreational pot in New Mexico this week?
Marijuana Industry NewsNew MexicoRecreational Marijuana March 28, 2022 0
This week: House set to vote on marijuana legalization bill
Marijuana Industry News March 28, 2022 0
Cannabis Ancillary Würk Adds 401(k) to Its SaaS-based HCM Toolbox
Marijuana Industry News March 28, 2022 0